- Report
- February 2026
- 250 Pages
Global
From €4046EUR$4,490USD£3,471GBP
- Report
- September 2026
- 198 Pages
Global
From €3194EUR$3,545USD£2,741GBP
€3549EUR$3,939USD£3,045GBP
- Report
- September 2026
- 193 Pages
Global
From €3194EUR$3,545USD£2,740GBP
€3549EUR$3,939USD£3,045GBP
- Report
- September 2026
- 198 Pages
Global
From €3194EUR$3,545USD£2,741GBP
€3549EUR$3,939USD£3,045GBP
- Report
- February 2026
- 250 Pages
Global
From €4046EUR$4,490USD£3,471GBP
- Report
- February 2026
- 250 Pages
Global
From €4046EUR$4,490USD£3,471GBP
- Report
- July 2026
- 200 Pages
Global
From €7200EUR$7,990USD£6,177GBP
- Report
- April 2026
- 165 Pages
Global
From €3559EUR$3,950USD£3,054GBP
The Cytokine Based Therapies market within the context of Oncology Drugs is a rapidly growing field of research and development. Cytokines are proteins that are released by cells and act as messengers between cells, and are used to treat a variety of cancers. Cytokine based therapies are used to stimulate the immune system to recognize and attack cancer cells, and can be used in combination with other treatments such as chemotherapy and radiation. These therapies are often used in combination with other treatments to improve the effectiveness of the treatment.
Cytokine based therapies are being developed by a number of companies, including Amgen, Bristol-Myers Squibb, Merck, and Novartis. These companies are researching and developing new treatments for a variety of cancers, including breast, lung, and prostate cancer. Additionally, these companies are also researching and developing treatments for other diseases, such as autoimmune diseases and infectious diseases. Show Less Read more